Collegium Pharmaceutical Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone, and thank you for joining us at the Barclays Miami conference. My name is Jenna Davidner. I'm one of the analysts here on the specialty pharmaceuticals team. and I have the pleasure of hosting Collegium Pharmaceuticals. Representing the company is the CEO, Vikram Karnani; on his -- on my left in the middle is the CFO, Colleen Tupper; and down on the end is the company's Chief Commercial Officer, Scott Dreyer.
So maybe to level set the conversation, Vikram it's been a big year. You are a more recent addition, new CEO. You guys made an acquisition towards the end of 2024, bringing in a new growth asset, diversifying the top line -- maybe you can just, first of all, give us a brief overview of the company and walk us through 2025. Maybe how you perform better or worse than you expected. There's a couple of guidance raises throughout the year.
Yes. Thanks, Jenna. Great to be here.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
